| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Lantern Pharma Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 20,000 | 18 Dec 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LTRN | Lantern Pharma Inc. | 18 Dec 2025 | 1 | $0 | 4 | Chief Financial Officer | 22 Dec 2025, 16:05 |
| LTRN | Lantern Pharma Inc. | 19 Sep 2025 | 4 | $0 | 4 | Chief Financial Officer | 23 Sep 2025, 16:05 |
| LTRN | Lantern Pharma Inc. | 15 Jul 2024 | 1 | $0 | 4 | Chief Financial Officer | 17 Jul 2024, 16:30 |
| LTRN | Lantern Pharma Inc. | 29 Oct 2021 | 1 | $0 | 4 | Chief Financial Officer | 02 Nov 2021, 16:05 |